Drug Safety In Pregnant Women: FDA Seeks Alternatives To Registries
This article was originally published in The Pink Sheet Daily
Executive Summary
Stakeholder meeting will address poor enrollment rates and other issues that undermine the utility of pregnancy registries, as well as the use of alternatives, such as case control studies and claims-based database studies.